Page last updated: 2024-10-31

metyrapone and Hepatitis, Chronic

metyrapone has been researched along with Hepatitis, Chronic in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Hepatitis, Chronic: INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KNICK, B1
BEHRENS, D1
ROTHER, F1
SACHSSE, W1

Other Studies

1 other study available for metyrapone and Hepatitis, Chronic

ArticleYear
[METOPIRON THERAPY OF THE "ESCAPE PHENOMENON" AFTER PROLONGED CORTICOSTEROID THERAPY IN SUBACUTE AND CHRONIC HEPATITIS].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1964, Volume: 70

    Topics: Adrenal Cortex Hormones; Hepatitis; Hepatitis A; Hepatitis, Chronic; Ketones; Metyrapone; Mineraloco

1964